2012
DOI: 10.1111/j.1365-2230.2011.04282.x
|View full text |Cite
|
Sign up to set email alerts
|

Quality of life in patients with pemphigus receiving adjuvant therapy

Abstract: We found no significant differences in QOL impairment between the treatment subgroups; however, we observed a strong association between psychiatric morbidity and poorer QOL within each of the treatment groups. This should be of concern for dermatologists, as psychiatric morbidity is associated with poor treatment adherence and dissatisfaction with care.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
31
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 24 publications
(33 citation statements)
references
References 17 publications
2
31
0
Order By: Relevance
“…The meta‐analysis indicated similar mean scores in the symptoms (35·8, 95% CI 32·7–38·9) and emotions (36·5, 95% CI 33·8–39·2) domains of Skindex‐29, whereas they were slightly lower for social functioning (32·8, 95% CI 29·9–35·6) (Fig. c) …”
Section: Selected Studiesmentioning
confidence: 82%
See 1 more Smart Citation
“…The meta‐analysis indicated similar mean scores in the symptoms (35·8, 95% CI 32·7–38·9) and emotions (36·5, 95% CI 33·8–39·2) domains of Skindex‐29, whereas they were slightly lower for social functioning (32·8, 95% CI 29·9–35·6) (Fig. c) …”
Section: Selected Studiesmentioning
confidence: 82%
“…Four types of dermatology‐ or oral‐disease‐specific tools were applied: DLQI, Skindex‐29, Skindex‐17 and Chronic Oral Mucosal Diseases Questionnaire. The most frequently used measures were SF‐36 (eight of 16), DLQI (five of 16) and Skindex‐29 (four of 16) …”
Section: Selected Studiesmentioning
confidence: 99%
“…These data from the German Registry of Autoimmune Diseases was updated recently in 36 PV patients showing a 94% partial or complete initial responsiveness to rituximab (15). While Faurschou and Gniadecki (22) used a second course of rituximab treatment 6 months after the first course, inducing some cases of complete remission, this would suggest that multiple courses of rituximab can be efficacious in partial (as well as non-) responders without serious morbidity and with an acceptable reported quality of life (23).…”
Section: Discussionmentioning
confidence: 97%
“…Like many other skin diseases, the QOL of females with AIBD was found to be affected more than the QOL of males in several studies to date (Paradisi et al, 2009, Paradisi et al, 2012, Sampogna et al, 2006). The significant impacts of AIBDs on QOL are due to factors such as time spent on treatment, financial burden, social misconceptions, physical discomfit and limitations, and poor mental health (Chee and Murrell, 2011, Sebaratnam et al, 2012).…”
Section: Quality Of Lifementioning
confidence: 93%